Entrada Therapeutics Inc (TRDA)
17.74
+0.14
(+0.82%)
USD |
NASDAQ |
Nov 04, 16:00
17.76
+0.01
(+0.06%)
After-Hours: 20:00
Entrada Therapeutics Total Assets (Quarterly): 581.96M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 581.96M |
| March 31, 2024 | 510.84M |
| December 31, 2023 | 469.19M |
| September 30, 2023 | 485.03M |
| June 30, 2023 | 493.98M |
| March 31, 2023 | 475.57M |
| December 31, 2022 | 252.06M |
| Date | Value |
|---|---|
| September 30, 2022 | 274.46M |
| June 30, 2022 | 295.92M |
| March 31, 2022 | 316.70M |
| December 31, 2021 | 305.83M |
| September 30, 2021 | 132.40M |
| June 30, 2021 | 143.51M |
| December 31, 2020 | 43.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
43.53M
Minimum
Dec 2020
581.96M
Maximum
Jun 2024
341.50M
Average
311.27M
Median
Total Assets (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 294.26M |
| Sarepta Therapeutics Inc | 3.424B |
| Catalyst Pharmaceuticals Inc | 706.36M |
| Vertex Pharmaceuticals Inc | 20.13B |
| Regenxbio Inc | 569.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 152.04M |
| Shareholders Equity (Quarterly) | 429.92M |
| Current Ratio | 5.705 |